BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

10 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonists.EBI
Merck Research Laboratories
Chromenones as potent bradykinin B1 antagonists.EBI
Amgen
Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.EBI
Amgen
Bradykinin B1 receptor antagonists as potential therapeutic agents for pain.EBI
Johnson & Johnson Pharmaceutical Research and Development
Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.EBI
Amgen
Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.EBI
Amgen
Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity.EBI
Amgen
Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.EBI
Merck Research Laboratories
2,3-diaminopyridine bradykinin B1 receptor antagonists.EBI
Merck Research Laboratories
Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies.EBI
Merck Research Laboratories